Equitable Access to High-Cost Pharmaceuticals - Image 1

£101.79

Academic Press Equitable Access to High-Cost Pharmaceuticals

Name: Equitable Access to High-Cost Pharmaceuticals
Brand: Academic Press
Price: 101.79 GBP
Availability: InStock

Economics

This is the most expensive it has ever been. Walk away.

£102 today · previous high £102 · all-time low £101

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↓ Price chart
when this has been cheap or pricey

↓ Forecast
where the price is heading next

↓ Statistics
all-time high & low, recent range

↑ Price alert
name your number, we'll email you

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 30 days • 30 data points (No recent data available)

Historical

Generating forecast...

Price Distribution

Price distribution over 30 days • 1 price levels

Days at Price

Price Analysis

Most common price: £102 (30 days, 100.0%)

Price range: £102 - £102

Price levels: 1 different prices over 30 days

Description

Equitable Access to High-Cost Pharmaceuticals seeks to aid the development and implementation of equitable public health policies by pharmaco-economics professionals, health economists, and policymakers. With detailed country-by country analysis of policy and regulation, the Work compares and contrasts national healthcare systems to support researchers and practitioners identify optimal healthcare policy solutions. The Work incorporates chapters on global regulatory changes, health technology assessment guidelines, and competitive effectiveness research recommendations from international bodies such as the OECD or the EU. Novel policies such as horizon scanning, managed-entry agreement and post-launch monitoring are considered in detail. The Work also thoroughly reviews novel pharmaceuticals with particular research interest, including cancer drugs, orphan medicines, Hep C, and personalized medicines. Evaluates impact and efficacy of current access policies and pricing regulation of high-cost drugs Incorporates existing guidelines and recommendations by international organizations Compares and contrasts how different countries fund and police high-cost drug access Explores novel and emergent policies, including managed entry agreement, analysis of real world data and differential pricing Reviews novel pharmaceuticals of current research interest

Product Specifications

Brand: Academic Press
Format: paperback
ASIN: 0128119454
Category: Books > Subjects > Business, Finance & Law > Economics
Domain: Amazon UK
Release Date: 16 March 2018
Listed Since: 13 September 2017

Barcode

No barcode data available

Academic Press Equitable Access to High-Cost Pharmaceuticals

This is the most expensive it has ever been. Walk away.

Price History & Forecast

Price Distribution

Price Analysis

Description

Product Specifications

Barcode

Similar Products You Might Like

Fundamentals of Market Access for Pharmaceuticals

Formulating and Implementing Pharmaceutical Pricing Policies: Challenges, Case Studies and Lessons Learned from Medicine Price Control

Global Pharmaceutical Policy: Ensuring Medicines for Tomorrow’s World

Pharmacoeconomics: From Theory to Practice

Pharmacoeconomics: From Theory to Practice

The Right Price: A Value-Based Prescription for Drug Costs

The Right Price: A Value-Based Prescription for Drug Costs

Competition Law and Policy in the Japanese Pharmaceutical Sector (Kobe University Monograph Series in Social Science Research)

The Public Financing of Pharmaceuticals: An Economic Approach

Economics of Drug R&D:Financing, Strategic and Policy Considerations; Price Regulation,Capital Market Imperfections and Strategic R&D Investment Behavior in the Pharmaceutical Industry

Intellectual Property, Pharmaceuticals and Public Health: Access to Drugs in Developing Countries

EU Competition Law and Pharmaceuticals (New Horizons in Competition Law and Economics series)

EU Law of Competition and Trade in the Pharmaceutical Sector (Elgar Competition Law and Practice series)

PHARMACEUTICAL ECONOMICS AND POLICY 3RD EDITION: Perspectives, Promises, and Problems

Economics of the Pharmaceutical and Medical Device Industry: Supply Chain, Trade and Innovation (Routledge Studies in the Economics of Innovation)

Pharmaceutical Innovation, Competition and Patent Law: A Trilateral Perspective

Global Issues in Pharmaceutical Marketing

The Price of Global Health: Drug Pricing Strategies to Balance Patient Access and the Funding of Innovation

The Politics of the Pharmaceutical Industry and Access to Medicines: World Pharmacy and India

Edward Elgar - Intellectual Property, Pharmaceuticals and Public Health

Pharmaceutical Economics (The International Library of Critical Writings in Economics series)

Boosting Pharmaceutical Innovation in the Post-TRIPS Era: Real-Life Lessons for the Developing World

Pharmaceuticals, Corporate Crime and Public Health

The Politics of the Pharmaceutical Industry and Access to Medicines: World Pharmacy and India